Osteoporosis and Fragility Fractures.

Osteoporosis fragility fracture hip fracture pharmacotherapy vertebral compression fracture

Journal

Rhode Island medical journal (2013)
ISSN: 2327-2228
Titre abrégé: R I Med J (2013)
Pays: United States
ID NLM: 101605827

Informations de publication

Date de publication:
03 Oct 2022
Historique:
entrez: 29 9 2022
pubmed: 30 9 2022
medline: 4 10 2022
Statut: epublish

Résumé

Osteoporosis and fragility fractures (FFs) are closely intertwined as the former is a common predisposing factor to the latter. This causal relationship is due to low bone density of osteoporosis and compromised bone microarchitecture, leading to structural failure, decreased ability to withstand applied stresses, and increased propensity to fracture. Osteoporosis can be idiopathic or due to a variety of secondary causes, and numerous treatment strategies are available. FFs are common injuries among the elderly and are caused by factors both intrinsic and extrinsic to the patient. The clinical and economic significances of osteoporosis and FFs are substantial, with considerable associated morbidity and mortality, and billions spent on healthcare expenditures in the US annually. Osteoporosis and FFs are two of the most important topics related to fracture liaison services (FLSs), and their understanding is integral to appreciating the benefits an FLS can provide for patients and providers.

Identifiants

pubmed: 36173904

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-21

Auteurs

Edward J Testa (EJ)

Department of Orthopedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI.

Tucker C Callanan (TC)

Department of Orthopedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI.

Andrew R Evans (AR)

Department of Orthopedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI.

Roy K Aaron (RK)

Department of Orthopedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH